Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 12 clinical trials
Blinatumomab Inotuzumab Ozogamicin and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia

This phase II trial studies how well blinatumomab, inotuzumab ozogamicin, and combination chemotherapy work as frontline therapy in treating patients with B acute lymphoblastic leukemia. Immunotherapy with monoclonal antibodies, such as blinatumomab, may induce changes in the body's immune system and may interfere with the ability of tumor cells to …

dexamethasone
combination chemotherapy
remission
rituximab
monoclonal antibody therapy
  • 0 views
  • 04 Mar, 2021
  • 1 location
Ibrutinib Obinutuzumab and Venetoclax for Patients With Chronic Lymphocytic Leukemia

Background: Chronic Lymphocytic Leukemia (CLL) is the most common leukemia in the occidental countries. Until now, it is considered a chronic disease without a cure. The development of new molecular therapies have showed that the cure may be an option. This protocol propose a triple sequential therapy with three direct …

monoclonal protein
tyrosine
obinutuzumab
venetoclax
btk inhibitor
  • 0 views
  • 23 Jan, 2021
  • 2 locations